RheumNow

COVID-19 Patient PSA Video Series

Save

By Rheumnow Admin

30 March 2020

Dr. Jack Cush provides a series of "Patient Safety Advisories" on how patients can cope with the COVID-19 pandemic and rheumatology-related illnesses.

Read Article

An Overview of Safety Data From the RINVOQ™ (upadacitinib) Phase 3 Program

Save

By Rheumnow Admin

02 December 2019

Dr. Stanley Cohen presents safety data from both the short-term controlled and long-term portions of the SELECT Phase 3 Program with RINVOQ™.

Read Article

Achieving Clinical Goals With RINVOQ™ (upadacitinib)

Save

By Rheumnow Admin

01 November 2019

Dr. Alvin Wells highlights data from the SELECT clinical program and discusses treatment goals in RA.

Read Article

Key Highlights From the SELECT-COMPARE Trial

Save

By Rheumnow Admin

04 October 2019

In this video, Dr. Roy Fleischmann discusses data from the SELECT-COMPARE trial with RINVOQ™ (upadacitinib).

Read Article

THE SCIENCE OF RINVOQ™ (UPADACITINIB)—A NEW JAK INHIBITOR

Save

By Rheumnow Admin

29 August 2019

The US FDA has recently approved a new treatment for rheumatoid arthritis. This article features selected highlights from the prescribing information and study results of this treatment.

Read Article

Contemporary Management of RA: Is an Inflection Point at Hand?

Save

By Rheumnow Admin

01 July 2019

This video features Dr. Alvin Wells, Dr. Roy Fleischmann, and Dr. Vibeke Strand discussing the goals of contemporary RA therapy, including the patient perspective, and the future of RA management.

Read Article

Biosimilars in Rheumatology

Save

By Rheumnow Admin

31 May 2019

A first-of-its kind educational video series focusing on the “hot topics” in biosimilars from the perspective of leading Rheumatology experts. This educational series is presented by Sandoz, Inc.

Read Article